Trampangic 37,5/325 FC tablets
PDF Leaflet Revision Date: 23 April 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Management of moderate to moderately-severe pain in adults.
Dosage (summary)
1-2 tablets every 4-6 hours as needed, max 8 tablets/day.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding due to potential risks.
Key Drug Interactions
- Serotonergic medicines
- Alcohol
- CYP2D6 inhibitors
- CYP3A4 inducers
- Opioid agonists-antagonists
Contraindications
- Hypersensitivity to tramadol or paracetamol
- Acute intoxication with CNS depressants
- Respiratory depression
- Seizure disorders
- Severe hepatic impairment
- Children under 12 years
Common side effects
- Nausea
- Dizziness
- Somnolence
- Constipation
- Pruritus
Counselling Points
- Do not exceed recommended dose.
- Avoid alcohol and CNS depressants.
- Monitor for signs of overdose.
- Inform about potential for dependence.
Serious warnings
- Risk of respiratory depression
- Potential for dependence and withdrawal symptoms
- Serotonin syndrome risk with serotonergic drugs
Important Disclaimer
The Trampangic 37,5/325 FC tablets professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
